Functional studies of the antigen binding site of an anti-haloperidol single-chain antibody 

Employing engineered exosomes for combating colon cancer and engineering CD38 as an optimized drug carrier 

Engineering viral vectors for gene and cell targeting 

Biochemical development and analysis of NAD⁺-related biomolecules 

mRNA display as a method to generate stable fibronectin ligands for the alpha 1 subunit of the nicotinic acetylcholine receptor 

Engineering chimeric antigen receptor (CAR) -modified T cells for enhanced cancer immunotherapy 

Colchicine protects mice from the lethal effect of agonistic anti -Fas antibody 

Detection of anti-Hu antibodies, a possible key to early diagnosis of small cell lung cancer 

The study of a novel disulfide-linked immunoconjugate of methotrexate with monoclonal anti-SSEA-1 IgM antibody 

Disrupted ER-to-Golgi trafficking underlies anti-HIV drugs and alcohol induced cellular stress and hepatic injury 

Targets of protein nitration during aging 

Antibody-cytokine/chemokine fusion proteins in the immunotherapy of solid tumors 

Construction and testing of chimeric antigen receptor targeting CS1 for treatment of primary effusion lymphoma 

Study of dendritic cell-specific lentivector vaccine system 

Investigating the effect of FLT3 tyrosine kinase inhibitors and anti-FLT3 antibody-based therapy in acute myeloid leukemia 

Peering into the cell: click chemistry and novel dyes towards enhanced biomedical imaging 

Studies of lacrimal gland immune cell homeostasis in polymeric immunoglobulin receptor (pIgR) knockout mice and evaluation of monoclonal dimeric IgA producing rabbit hybridomas 

Targeted cell imaging by in-situ assembly and activation of hot spot SERS nanoprobes using split-fluorescent protein scaffolds 

Generation and characterization of peptide theranostics by mRNA display 

Molecular interactions between haloperidol and anti-haloperidol monoclonal antibodies : relationships with dopamine receptor binding 

Anti-Hu immuno-responsivenss in small-cell lung cancer 

Directed evolution of high affinity, cyclic, protease resistant peptides using mRNA display 

EXSAN: explicit solvent anchored fragment-base docking 

Studies of antibody heterogeneity of affinity for hapten 

Tri-specific T cell engager immunotherapy targeting tumor initiating cells